Blunt instruments: Schizophrenia drugs
Study Finds Little Advantage in New Schizophrenia Drugs - New York Times
Looks like the current crop of schizophrenia drugs come up short.
The study, which looked at four new-generation drugs, called atypical antipsychotics, and one older drug, found that all five blunted the symptoms of schizophrenia, a disabling disorder that affects three million Americans. But almost three-quarters of the patients who participated stopped taking the drugs they were on because of discomfort or specific side effects.